Exogenous CXCL8 added to pancreatic cancer cells in vitro increased their invasion ability, tumorsphere formation, and CSC population and addition of a CXCR1-blocking monoclonal antibody was able to revert all these effects (15). Here, CXCR1 is linked to pancreatic neoplasm.